| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Newsummit Biopharma Holdings (NSB) | Oppenheimer & Co./ Cowen and Company | $80.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| none | ||||||
| Withdrawn | ||||||
| none | ||||||
| New Terms | ||||||
| BATS Global Markets (BATS) | Morgan Stanley/ Citigroup/ Credit Suisse | $100.00 | 2-Stars | |||
| Enphase Energy (ENPH) | Morgan Stanley/ BofA Merrill Lynch/ Deutsche Bank Securities | $100.00 | 2-Stars | |||
| ExactTarget (ET) | J.P. Morgan/ Deutsche Bank Secutities/ Stifel, Nicolaus Weisel | $100.00 | 2-Stars | |||
| Nationstar Mortgage Holdings (NSM) | BofA Merrill Lynch/Citigroup/ Credit Suisse/ Wells Fargo Securities | 16.67 | $17.00 | $19.00 | $300.00 | n.a. |
| Provident Mortgage Capital Associates (PMCA) | UBS Investment Bank/ Credit Suisse/ Deutsche Bank Securities | 8.33 | $15.00 | $15.00 | $125.00 | 1-Star |
| Vantiv (VNTV) | J.P. Morgan/ Morgan Stanley/ Credit Suisse/ Goldman, Sachs & Co./ Deutsche Bank Securities | $100.00 | 2-Stars | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Weeks of Feb. 20, 2012 | Manager(s) | Offered | Raised | Price | 2/24/12 | Change |
| Proto Labs (PRLB) | Jefferies/ Piper Jaffray | 4.30 | $68.80 | $16.00 | $29.00 | 81.25% |
| Bazaarvoice (BV) | Morgan Stanley/ Deutsche Bank Securities/ Credit Suisse | 9.48 | $113.81 | $12.00 | $16.51 | 37.58% |
| Ceres (CERE) | Goldman, Sachs/ Barclays Capital | 5.00 | $65.00 | $13.00 | $14.95 | 15.00% |
| ROI Acquisition (ROIQU) (u) | Deutsche Bank Securities | 7.50 | $75.00 | $10.00 | $10.01 | 0.10% |
